Fifth Third Bancorp’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-113
| Closed | -$19K | – | 2803 |
|
|
2021
Q2 | $19K | Sell |
113
-5
| -4% | -$835 | ﹤0.01% | 1816 |
|
|
2021
Q1 | $18K | Hold |
118
| – | – | ﹤0.01% | 1826 |
|
|
2020
Q4 | $15K | Buy |
118
+88
| +293% | +$9.84K | ﹤0.01% | 1807 |
|
|
2020
Q3 | $3K | Hold |
30
| – | – | ﹤0.01% | 2005 |
|
|
2020
Q2 | $3K | Sell |
30
-1,049
| -97% | -$97.6K | ﹤0.01% | 1962 |
|
|
2020
Q1 | $90K | Buy |
1,079
+137
| +15% | +$13.4K | ﹤0.01% | 1072 |
|
|
2019
Q4 | $105K | Buy |
942
+189
| +25% | +$19.4K | ﹤0.01% | 1143 |
|
|
2019
Q3 | $75K | Buy |
753
+120
| +19% | +$11.9K | ﹤0.01% | 1228 |
|
|
2019
Q2 | $63K | Buy |
633
+211
| +50% | +$20.1K | ﹤0.01% | 1272 |
|
|
2019
Q1 | $47K | Buy |
422
+77
| +22% | +$8.05K | ﹤0.01% | 1303 |
|
|
2018
Q4 | $32K | Sell |
345
-63
| -15% | -$6.37K | ﹤0.01% | 1389 |
|
|
2018
Q3 | $45K | Sell |
408
-28
| -6% | -$2.92K | ﹤0.01% | 1357 |
|
|
2018
Q2 | $41K | Buy |
436
+26
| +6% | +$2.24K | ﹤0.01% | 1387 |
|
|
2018
Q1 | $34K | Sell |
410
-29
| -7% | -$2.58K | ﹤0.01% | 1480 |
|
|
2017
Q4 | $40K | Sell |
439
-392
| -47% | -$32.6K | ﹤0.01% | 1344 |
|
|
2017
Q3 | $63K | Buy |
831
+720
| +649% | +$54.4K | ﹤0.01% | 1223 |
|
|
2017
Q2 | $8K | Buy |
111
+67
| +152% | +$4.64K | ﹤0.01% | 1802 |
|
|
2017
Q1 | $3K | Buy |
+44
| New | +$2.59K | ﹤0.01% | 1955 |
|
|
2015
Q4 | – | Sell |
-21
| Closed | -$1K | – | 2945 |
|
|
2015
Q3 | $1K | Buy |
+21
| New | +$841 | ﹤0.01% | 2822 |
|
Other funds holding PRAH
Fifth Third Bancorp's PRAH Position: Q3 2021 in Review
Fifth Third Bancorp sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 113 shares — an estimated $19K sold.
Fifth Third Bancorp first reported a position in PRAH in Q3 2015 and held it in 19 quarters. The position peaked at $105K in Q4 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Fifth Third Bancorp reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Fifth Third Bancorp sold 113 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $19K.
- Fifth Third Bancorp first reported a position in PRA Health Sciences, Inc. in Q3 2015 and held it in 19 quarters.
- Fifth Third Bancorp's PRA Health Sciences, Inc. position peaked at $105K in Q4 2019.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Fifth Third Bancorp's 13F filing for Q3 2021, filed 15 Oct 2021.